Aerovate Therapeutics
NASDAQ: AVTE
Healthcare
Biotechnology
Rank
#25412
Market Cap
77.68 M
Volume
29,370
Price
93.80
Change (%)
3400.00%
Country or region
United States
United States
Aerovate Therapeutics Stock Split History Overview
This company has undergone a total of 1 stock splits throughout its history. 1 reverse splits occurred, consolidating shares and stabilizing stock prices. The most recent split occurred on April 29, 2025 with a ratio of 1-for-35. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
Aerovate Therapeutics (NASDAQ: AVTE) Stock Split History
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| April 29, 2025 | 1:35 | x0.028571429 | x0.028571429 | Reverse |
Frequently Asked Questions
If Aerovate Therapeutics (stock symbol: NASDAQ: AVTE) had never undergone any stock splits, its price per share today would be approximately 2.68 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-35) that occurred on April 29, 2025.
Aerovate Therapeutics (stock symbol: NASDAQ: AVTE) has undergone a total of 1 stock splits. The most recent split occurred on April 29, 2025. One share bought prior to the first split on April 29, 2025 would now equal 0.03 shares.
Aerovate Therapeutics (stock symbol: NASDAQ: AVTE) has undergone 1 stock splits in its history. The most recent split, a 1-for-35 split, occurred on April 29, 2025. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.